John E. Davis - 12 Aug 2025 Form 4 Insider Report for ARTIVION, INC. (AORT)

Reporting relationship: Chief Commercial Officer
Issuer ticker: AORT
Reported as of: 12 Aug 2025
Net transaction value: -$188,311
SEC form: 4
Accepted by SEC: 14 Aug 2025, 09:56:50 UTC
Prior SEC filing: 12 Mar 2025
Next SEC filing: 12 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ John E. Davis

Key filing fact

John E. Davis filed Form 4 for ARTIVION, INC. (AORT) on 14 Aug 2025.

Key facts

This page summarizes John E. Davis's Form 4 filing for ARTIVION, INC. (AORT).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 Aug 2025, 09:56.

Change

Previous filing in this sequence was filed on 12 Mar 2025.
Current net transaction value: -$188,311.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001653206 Primary reporting owner

Davis John E

Relationship: Chief Commercial Officer
Address: 1655 ROBERTS BLVD., NW, KENNESAW
Signature: /s/ John E. Davis
Signature date: 14 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AORT transaction

Common Stock

Options Exercise

Transaction value: $283,444
Shares: +10,802
Change %: +5.2%
Price: $26.24
Shares after: 219,580
Date: 12 Aug 2025
Ownership: Direct

AORT transaction

Common Stock

Sale

Transaction value: $471,756
Shares: -10,802
Change %: -4.9%
Price: $43.67
Shares after: 208,778
Date: 12 Aug 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AORT transaction Derivative

Stock Options (Right to buy)

Options Exercise

Transaction value: $0
Shares: -10,802
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 12 Aug 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,802
Exercise price: $26.24
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Reflects weighted average price. Range of prices were between $43.470 to $43.835. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F2

Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was February 19, 2021.